-
Clinical Endpoints Study for TUBERCULOSIS CUTANEOUS
Regular price From €2.000,00 EURRegular priceUnit price per -
Clinical Endpoints Study for TUBERCULOSIS, CUTANEOUS
Regular price From €2.000,00 EURRegular priceUnit price per -
Expert mapping Study for TUBERCULOSIS, CUTANEOUS
Regular price From €1.500,00 EURRegular priceUnit price per -
Safety Shield Study for PRETOMANID
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for DELAMANID
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for BEDAQUILINE
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for RIFAPENTINE
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for RIFABUTIN
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for PYRAZINAMIDE
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for ETHAMBUTOL
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for ISONIAZID
Regular price From €800,00 EURRegular priceUnit price per
Explore our exclusive study series
-
Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80%...
-
Expert Mapping Studies
Expert Mapping Reports cut screening time by 10 days and reduce failed...
-
Clinical Endpoints Studies
This targeted analysis delivers a robust assessment of clinical endpoints tailored to...
